Is POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME a side effect of MYCOPHENOLATE MOFETIL ? ( FactMed.com )

About this FactMed analysis covering adverse side effect reports of MYCOPHENOLATE MOFETIL patients who developed POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 52 individuals taking MYCOPHENOLATE MOFETIL reported POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME to the FDA. A total of 16895 MYCOPHENOLATE MOFETIL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between MYCOPHENOLATE MOFETIL and POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. In doing so, we compare MYCOPHENOLATE MOFETIL with other drugs that cause POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME, to help you evaluate whether or not MYCOPHENOLATE MOFETIL causes POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME. Likewise, this page shows the most highly-reported side effects of MYCOPHENOLATE MOFETIL, so you can see if POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME ranks among MYCOPHENOLATE MOFETIL's most well-known side effects.

Summary Statistics
Reports of MYCOPHENOLATE MOFETIL causing POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME: 52
Reports of any side effect of MYCOPHENOLATE MOFETIL : 16895
Percentage of MYCOPHENOLATE MOFETIL patients where POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME is a reported side effect: 0.3078%

FDA reports of any drug causing POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME : 776
Average percentage for all medicated patients where POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME is reported as a complication: 0.0049%

Physician opinion on MYCOPHENOLATE MOFETIL as adverse event culprit:

Overall opinion for all reports of this drug:

Most frequent diagnoses/indications for prescribing MYCOPHENOLATE MOFETIL:

RENAL TRANSPLANT ( 1699 patients )
IMMUNOSUPPRESSION ( 1055 patients )
PROPHYLAXIS AGAINST TRANSPLANT REJECTION ( 714 patients )
PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE ( 597 patients )
DRUG USE FOR UNKNOWN INDICATION ( 399 patients )
LIVER TRANSPLANT ( 360 patients )
IMMUNOSUPPRESSANT DRUG THERAPY ( 310 patients )
HEART TRANSPLANT ( 285 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 221 patients )
LUPUS NEPHRITIS ( 173 patients )
SYSTEMIC LUPUS ERYTHEMATOSUS ( 173 patients )
LUNG TRANSPLANT ( 136 patients )
GRAFT VERSUS HOST DISEASE ( 128 patients )
STEM CELL TRANSPLANT ( 104 patients )
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS ( 46 patients )
PROPHYLAXIS ( 45 patients )
TRANSPLANT ( 43 patients )
RENAL AND PANCREAS TRANSPLANT ( 37 patients )
WEGENER'S GRANULOMATOSIS ( 34 patients )
CORD BLOOD TRANSPLANT THERAPY ( 34 patients )
KIDNEY TRANSPLANT REJECTION ( 34 patients )
TRANSPLANT REJECTION ( 33 patients )
LIVER TRANSPLANT REJECTION ( 33 patients )
NEPHROTIC SYNDROME ( 32 patients )
CHRONIC GRAFT VERSUS HOST DISEASE ( 31 patients )
EVANS SYNDROME ( 31 patients )
PEMPHIGUS ( 31 patients )
UVEITIS ( 30 patients )
BONE MARROW TRANSPLANT ( 29 patients )
ACUTE GRAFT VERSUS HOST DISEASE ( 28 patients )
VASCULITIS ( 27 patients )
DRUG EXPOSURE DURING PREGNANCY ( 26 patients )
PYODERMA GANGRENOSUM ( 26 patients )
MYASTHENIA GRAVIS ( 24 patients )
ACUTE MYELOID LEUKAEMIA ( 21 patients )
DERMATITIS ATOPIC ( 19 patients )
AUTOIMMUNE HEPATITIS ( 18 patients )
MULTIPLE MYELOMA ( 12 patients )
AUTOIMMUNE DISORDER ( 11 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 11 patients )
PANCREAS TRANSPLANT ( 11 patients )
ORGAN TRANSPLANT ( 10 patients )
RENAL VASCULITIS ( 10 patients )
BEHCET'S SYNDROME ( 9 patients )
CROHN'S DISEASE ( 9 patients )
DERMATOMYOSITIS ( 9 patients )
RHEUMATOID ARTHRITIS ( 8 patients )
INTERSTITIAL LUNG DISEASE ( 7 patients )
RENAL AND LIVER TRANSPLANT ( 7 patients )
POLYMYOSITIS ( 6 patients )
MYELODYSPLASTIC SYNDROME ( 6 patients )
CHORIORETINOPATHY ( 6 patients )
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS ( 6 patients )
GLOMERULONEPHRITIS PROLIFERATIVE ( 6 patients )
SCLERODERMA ( 6 patients )
DEMYELINATING POLYNEUROPATHY ( 6 patients )
SJOGREN'S SYNDROME ( 6 patients )
LUNG TRANSPLANT REJECTION ( 5 patients )
RENAL FAILURE ( 5 patients )
CONJUNCTIVITIS ( 5 patients )
HISTOPLASMOSIS ( 5 patients )
MULTIPLE SCLEROSIS ( 5 patients )
IDIOPATHIC THROMBOCYTOPENIC PURPURA ( 5 patients )
ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY ( 5 patients )
SCLERITIS ( 5 patients )
HEART TRANSPLANT REJECTION ( 5 patients )
RENAL AND PANCREAS TRANSPLANT REJECTION ( 5 patients )
GLOMERULONEPHRITIS ( 5 patients )
GLOMERULONEPHRITIS MEMBRANOUS ( 5 patients )
COLITIS ULCERATIVE ( 4 patients )
POSTOPERATIVE CARE ( 4 patients )
HEPATIC NEOPLASM MALIGNANT ( 4 patients )
PROTEINURIA ( 4 patients )
SYSTEMIC SCLEROSIS ( 4 patients )
GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE ( 4 patients )
CRYOGLOBULINAEMIA ( 4 patients )
LICHEN SCLEROSUS ( 4 patients )
PUSTULAR PSORIASIS ( 4 patients )
HEART AND LUNG TRANSPLANT ( 4 patients )
APLASTIC ANAEMIA ( 4 patients )
FOCAL SEGMENTAL GLOMERULOSCLEROSIS ( 4 patients )
KERATITIS HERPETIC ( 4 patients )
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN ( 4 patients )
LICHEN PLANUS ( 4 patients )
IGA NEPHROPATHY ( 4 patients )
APLASIA PURE RED CELL ( 4 patients )
JUVENILE ARTHRITIS ( 3 patients )
KERATOPLASTY ( 3 patients )
POLYCHONDRITIS ( 3 patients )
POLYNEUROPATHY ( 3 patients )
INFLAMMATORY BOWEL DISEASE ( 3 patients )
BLASTOMYCOSIS ( 3 patients )
LUNG DISORDER ( 2 patients )
NEPHROPATHY ( 2 patients )
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME ( 2 patients )
CONNECTIVE TISSUE DISORDER ( 2 patients )
OFF LABEL USE ( 2 patients )
PSORIATIC ARTHROPATHY ( 2 patients )
THROMBOCYTOPENIA ( 2 patients )
ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY ( 2 patients )
URTICARIA CHRONIC ( 2 patients )
ARTHRITIS ( 2 patients )
LUPUS ENCEPHALITIS ( 2 patients )
SMALL INTESTINE TRANSPLANT ( 2 patients )
INTESTINAL TRANSPLANT ( 2 patients )
HEPATITIS C ( 2 patients )
PSORIASIS ( 2 patients )
CUTANEOUS LUPUS ERYTHEMATOSUS ( 2 patients )
MYELOPROLIFERATIVE DISORDER ( 2 patients )
PULMONARY FIBROSIS ( 2 patients )
CARDIOMYOPATHY ( 2 patients )
MYOSITIS ( 2 patients )
HAEMATOLOGICAL MALIGNANCY ( 2 patients )
SKIN GRAFT ( 1 patients )
INFECTION ( 1 patients )
ARTHRALGIA ( 1 patients )
HEPATIC CIRRHOSIS ( 1 patients )
SKIN ULCER ( 1 patients )
ECZEMA ( 1 patients )
NEUROMYELITIS OPTICA ( 1 patients )
NEUROPSYCHIATRIC LUPUS ( 1 patients )
RENAL IMPAIRMENT ( 1 patients )
HEPATITIS C POSITIVE ( 1 patients )
MORPHOEA ( 1 patients )
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE ( 1 patients )
RENAL TUBULAR NECROSIS ( 1 patients )
CORNEAL TRANSPLANT ( 1 patients )
ACUTE LYMPHOCYTIC LEUKAEMIA ( 1 patients )
BLOOD IMMUNOGLOBULIN D INCREASED ( 1 patients )
LEUKOCYTOCLASTIC VASCULITIS ( 1 patients )
GLOMERULONEPHRITIS MINIMAL LESION ( 1 patients )
PEMPHIGOID ( 1 patients )
CYTOMEGALOVIRUS INFECTION ( 1 patients )
ILL-DEFINED DISORDER ( 1 patients )
MYOCLONUS ( 1 patients )
LIVER AND SMALL INTESTINE TRANSPLANT ( 1 patients )
POLYARTERITIS NODOSA ( 1 patients )
SECONDARY IMMUNODEFICIENCY ( 1 patients )
IMMUNOMODULATORY THERAPY ( 1 patients )
NECROTISING SCLERITIS ( 1 patients )
RASH ( 1 patients )
ULCERATIVE KERATITIS ( 1 patients )
ANTISYNTHETASE SYNDROME ( 1 patients )
CHRONIC ALLOGRAFT NEPHROPATHY ( 1 patients )
SKIN CANCER ( 1 patients )
DIFFUSE VASCULITIS ( 1 patients )
NEPHRITIC SYNDROME ( 1 patients )
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY ( 1 patients )
SKIN LESION ( 1 patients )
VASCULAR OPERATION ( 1 patients )
CONGENITAL NEPHROTIC SYNDROME ( 1 patients )
HEPATIC NECROSIS ( 1 patients )
ERYTHEMA MULTIFORME ( 1 patients )
NEUROPATHY ( 1 patients )
RENAL FAILURE CHRONIC ( 1 patients )
CONJUNCTIVOPLASTY ( 1 patients )
MIXED CONNECTIVE TISSUE DISEASE ( 1 patients )
SYMPATHETIC OPHTHALMIA ( 1 patients )
BASAL CELL CARCINOMA ( 1 patients )
OCULAR HYPERTENSION ( 1 patients )
HERPES OPHTHALMIC ( 1 patients )
SYSTEMIC LUPUS ERYTHEMATOSUS RASH ( 1 patients )
HYPOVOLAEMIA ( 1 patients )
TAKAYASU'S ARTERITIS ( 1 patients )
BONE MARROW CONDITIONING REGIMEN ( 1 patients )
PANNICULITIS ( 1 patients )
SARCOIDOSIS ( 1 patients )
ALVEOLITIS ( 1 patients )
LINEAR IGA DISEASE ( 1 patients )
IMMUNOGLOBULINS INCREASED ( 1 patients )
TUBULOINTERSTITIAL NEPHRITIS AND UVEITIS SYNDROME ( 1 patients )
CHOROIDITIS ( 1 patients )
POLYARTHRITIS ( 1 patients )
NEOPLASM MALIGNANT ( 1 patients )
RASH MACULO-PAPULAR ( 1 patients )
URINARY SEDIMENT PRESENT ( 1 patients )
( 0 patients )

Drugs with high FDA adverse event association with POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME:

CYCLOSPORINE (119 patients)
PREDNISOLONE (114 patients)
METHOTREXATE (110 patients)
CYCLOPHOSPHAMIDE (103 patients)
VINCRISTINE (77 patients)
CYTARABINE (76 patients)
DEXAMETHASONE (75 patients)
TACROLIMUS (63 patients)
METHYLPREDNISOLONE (59 patients)
MYCOPHENOLATE MOFETIL (52 patients)
PREDNISONE (49 patients)
NEORAL (40 patients)
RITUXIMAB (36 patients)
CNTO 1275 (36 patients)
LASIX (34 patients)
BUSULFAN (34 patients)
AVASTIN (33 patients)
GABAPENTIN (32 patients)
PROGRAF (32 patients)
DOXORUBICIN HCL (29 patients)
OMEPRAZOLE (28 patients)
ETOPOSIDE (28 patients)
DECADRON (28 patients)
PREDNISONE TAB (27 patients)
CARBOPLATIN (27 patients)
ACETAMINOPHEN (26 patients)
ASPIRIN (26 patients)
LYRICA (26 patients)
ELSPAR (23 patients)
ZOFRAN (23 patients)
STELARA (23 patients)
OXALIPLATIN (22 patients)
MELPHALAN HYDROCHLORIDE (22 patients)
AMLODIPINE (22 patients)
GILENYA (22 patients)
ANTI-THYMOCYTE GLOBULIN NOS (21 patients)
FLUOROURACIL (21 patients)
CISPLATIN (21 patients)
VFEND (20 patients)
FENTANYL (19 patients)
EPOGEN (19 patients)
GEMCITABINE HYDROCHLORIDE (18 patients)
REBIF (18 patients)
DEXAMETHASONE SODIUM PHOSPHATE (18 patients)
GEMCITABINE (18 patients)
PACLITAXEL (18 patients)
AMPHOTERICIN B (17 patients)
ASPARAGINASE (17 patients)
KEPPRA (17 patients)
SOLU-MEDROL (16 patients)
PROPOFOL (16 patients)
VITAMIN D (15 patients)
NEXIUM (15 patients)
LISINOPRIL (15 patients)
MYCOPHENOLATE MOFETIL (CELLCEPT) (15 patients)
LEUCOVORIN CALCIUM (15 patients)
LEVOTHYROXINE SODIUM (15 patients)
VORICONAZOLE (15 patients)
XANAX (15 patients)
THIOTEPA (15 patients)
LEFLUNOMIDE (14 patients)
KETAMINE HCL (14 patients)
FLUDARABINE PHOSPHATE (13 patients)
FAMOTIDINE (13 patients)
FUROSEMIDE (13 patients)
HYDROXYCHLOROQUINE SULFATE (12 patients)
ALLOPURINOL (12 patients)
ATIVAN (12 patients)
FLUCONAZOLE (12 patients)
VANCOMYCIN (12 patients)
FTY 720 (12 patients)
CLOPIDOGREL (12 patients)
EPINEPHRINE (12 patients)
STEROIDS NOS (11 patients)
ACYCLOVIR (11 patients)
ALEMTUZUMAB (11 patients)
AMBIEN (11 patients)
CRESTOR (11 patients)
VALACYCLOVIR HYDROCHLORIDE (11 patients)
BLEOMYCIN SULFATE (11 patients)
DAUNORUBICIN HCL (11 patients)
RANITIDINE (11 patients)
FOLIC ACID (10 patients)
TAXOL (10 patients)
HUMIRA (10 patients)
SYNTHROID (10 patients)
VELCADE (10 patients)
HALOPERIDOL (10 patients)
PROCARBAZINE (10 patients)
DOCETAXEL (10 patients)
EMBEDA (10 patients)
LOXOPROFEN SODIUM (9 patients)
OXYCONTIN (9 patients)
ALKERAN (9 patients)
PHENYTOIN (9 patients)
PEPCID (9 patients)
MABTHERA (9 patients)
DOXORUBICIN (9 patients)
POTASSIUM CHLORIDE (9 patients)
PRILOSEC (9 patients)
LIDOCAINE (9 patients)
CEPHALEXIN (9 patients)
MORPHINE SULFATE (9 patients)
TOPAMAX (9 patients)
CLONAZEPAM (9 patients)
GENTAMICIN (8 patients)
HYDRALAZINE HCL (8 patients)
ACTONEL (8 patients)
METOPROLOL TARTRATE (8 patients)
AFLIBERCEPT (8 patients)
GTN SPRAY (8 patients)
MESNA (8 patients)
MORPHINE (8 patients)
ARAVA (8 patients)
IMMUNE GLOBULIN NOS (8 patients)
SUTENT (8 patients)
BEVACIZUMAB (8 patients)
BISOPROLOL FUMARATE (8 patients)
VOTRIENT (8 patients)
LORAZEPAM (8 patients)
METHOTREXATE SODIUM (8 patients)
HYDROCHLOROTHIAZIDE (8 patients)
EMEND (8 patients)
CELEBREX (8 patients)
METHYLPREDNISOLONE SODIUM SUCCINATE (8 patients)
MOTRIN (8 patients)
MULTI-VITAMINS (8 patients)
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (8 patients)
ITRACONAZOLE (8 patients)
CODEINE (8 patients)
TOCILIZUMAB (8 patients)
TRAZODONE HCL (8 patients)
URSODIOL (8 patients)
ESTRADIOL (7 patients)
EZETIMIBE (7 patients)
HYDROCORTISONE (7 patients)
DOCUSATE SODIUM (7 patients)
ATENOLOL (7 patients)
ATROVENT (7 patients)
OXYCODONE HCL (7 patients)
BETASERON (7 patients)
PHENERGAN (7 patients)
HEPARIN (7 patients)
MEROPENEM (7 patients)
CARVEDILOL (7 patients)
METRONIDAZOLE (7 patients)
SIMVASTATIN (7 patients)
EPREX (7 patients)
CO-CODAMOL (7 patients)
TRIAMCINOLONE (6 patients)
MULTIHANCE (6 patients)
URSO 250 (6 patients)
WHOLE BLOOD (6 patients)
VINBLASTINE SULFATE (6 patients)
INVANZ (6 patients)
ALBUTEROL (6 patients)
LORTAB (6 patients)
DACARBAZINE (6 patients)
THYMOGLOBULIN (6 patients)
IMIPENEM AND CILASTATIN SODIUM (6 patients)
NOVALGIN (6 patients)
IXEMPRA KIT (6 patients)
LANSOPRAZOLE (6 patients)
FLUDARA (6 patients)
VALIUM (6 patients)
LEVOFLOXACIN (6 patients)
ZYRTEC (6 patients)
ASPEGIC 1000 (6 patients)
TRAMADOL HCL (6 patients)
VALGANCICLOVIR HCL (6 patients)
TYLENOL (6 patients)
PANTOPRAZOLE (6 patients)
PINORUBIN (6 patients)
GAMMAGARD LIQUID (6 patients)
VINCRISTINE SULFATE (6 patients)
DIFLUCAN (6 patients)
PYOSTACINE (6 patients)
REMICADE (6 patients)
RHUMAB-VEGF (6 patients)
DOXYCYCLINE (6 patients)
ROCURONIUM BROMIDE (6 patients)
HYDROCORTISONE SODIUM PHOSPHATE (6 patients)
SEVOFLURANE (6 patients)
IBUPROFEN (6 patients)
IDARUBICIN HCL (6 patients)
CIPROFLOXACIN (6 patients)
OLOPATADINE HCL (6 patients)
CITALOPRAM HYDROBROMIDE (6 patients)
DEPOCYT (5 patients)
NIFEDIPINE (5 patients)
ADVAIR DISKUS 100/50 (5 patients)
L-PAM (5 patients)
KLOR-CON (5 patients)
LANTUS (5 patients)
REVLIMID (5 patients)
MIRALAX (5 patients)
LIPITOR (5 patients)
TEMSIROLIMUS (5 patients)
BASILIXIMAB (5 patients)
FILGRASTIM (5 patients)
IRINOTECAN HCL (5 patients)
VALCYTE (5 patients)
FLAGYL (5 patients)
PAXIL (5 patients)
CELLCEPT (5 patients)
SODIUM CHLORIDE (5 patients)
IMMUNE GLOBULIN (HUMAN) (5 patients)
TRAMADOL (5 patients)
CIPROFLOXACIN HYDROCHLORIDE (5 patients)
THALOMID (5 patients)

Most common side effects for patients taking MYCOPHENOLATE MOFETIL:

CYTOMEGALOVIRUS INFECTION (1602 patients)
PYREXIA (1360 patients)
DIARRHOEA (1252 patients)
BLOOD CREATININE INCREASED (1053 patients)
PNEUMONIA (991 patients)
TRANSPLANT REJECTION (865 patients)
SEPSIS (848 patients)
URINARY TRACT INFECTION (812 patients)
KIDNEY TRANSPLANT REJECTION (800 patients)
RENAL IMPAIRMENT (751 patients)
ANAEMIA (720 patients)
RENAL FAILURE ACUTE (568 patients)
LEUKOPENIA (557 patients)
RENAL FAILURE (544 patients)
VOMITING (535 patients)
NAUSEA (500 patients)
DEATH (493 patients)
MULTI-ORGAN FAILURE (471 patients)
ABDOMINAL PAIN (465 patients)
PLEURAL EFFUSION (446 patients)
DEHYDRATION (432 patients)
DRUG INEFFECTIVE (426 patients)
LYMPHOCELE (416 patients)
PANCYTOPENIA (408 patients)
COMPLICATIONS OF TRANSPLANTED KIDNEY (405 patients)
RESPIRATORY FAILURE (404 patients)
HYPERTENSION (402 patients)
HAEMOGLOBIN DECREASED (391 patients)
INFECTION (376 patients)
HAEMODIALYSIS (370 patients)
DRUG INTERACTION (360 patients)
THROMBOCYTOPENIA (356 patients)
HYPOTENSION (346 patients)
GRAFT VERSUS HOST DISEASE (322 patients)
DYSPNOEA (321 patients)
GASTROINTESTINAL HAEMORRHAGE (313 patients)
ENTEROCOCCAL INFECTION (299 patients)
CYTOMEGALOVIRUS VIRAEMIA (294 patients)
THROMBOTIC MICROANGIOPATHY (290 patients)
HERPES ZOSTER (284 patients)
STAPHYLOCOCCAL INFECTION (284 patients)
OEDEMA PERIPHERAL (283 patients)
HAEMATOMA (280 patients)
LIVER TRANSPLANT REJECTION (272 patients)
DIABETES MELLITUS (272 patients)
NEUTROPENIA (269 patients)
ASTHENIA (268 patients)
SEPTIC SHOCK (266 patients)
ESCHERICHIA INFECTION (262 patients)
WHITE BLOOD CELL COUNT DECREASED (258 patients)
ASCITES (256 patients)
ACUTE GRAFT VERSUS HOST DISEASE (251 patients)
HEADACHE (246 patients)
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER (246 patients)
PYELONEPHRITIS (245 patients)
DISEASE RECURRENCE (239 patients)
NEPHROPATHY TOXIC (237 patients)
PROTEINURIA (227 patients)
WEIGHT DECREASED (220 patients)
COUGH (219 patients)
BLOOD BILIRUBIN INCREASED (219 patients)
CELLULITIS (213 patients)
TREMOR (211 patients)
CONVULSION (210 patients)
ASPERGILLOSIS (209 patients)
PERITONITIS (209 patients)
DRUG TOXICITY (207 patients)
GRAFT DYSFUNCTION (204 patients)
PSEUDOMONAS INFECTION (203 patients)
UROSEPSIS (203 patients)
CARDIAC ARREST (201 patients)
OEDEMA (200 patients)
CARDIAC FAILURE (193 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (191 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN (188 patients)
GASTROENTERITIS (187 patients)
HAEMATURIA (186 patients)
CANDIDIASIS (186 patients)
MYOCARDIAL INFARCTION (184 patients)
MALAISE (183 patients)
ALANINE AMINOTRANSFERASE INCREASED (182 patients)
CHRONIC ALLOGRAFT NEPHROPATHY (182 patients)
CHOLESTASIS (180 patients)
BACK PAIN (178 patients)
LYMPHOPROLIFERATIVE DISORDER (176 patients)
BACTERIAL INFECTION (175 patients)
ATRIAL FIBRILLATION (169 patients)
RENAL TUBULAR NECROSIS (169 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (168 patients)
BRONCHOPULMONARY ASPERGILLOSIS (167 patients)
HYPERKALAEMIA (166 patients)
PLATELET COUNT DECREASED (164 patients)
POST PROCEDURAL COMPLICATION (164 patients)
ABDOMINAL PAIN UPPER (162 patients)
LUNG INFILTRATION (161 patients)
AGRANULOCYTOSIS (161 patients)
APLASIA PURE RED CELL (160 patients)
EPSTEIN-BARR VIRUS INFECTION (160 patients)
PAIN (160 patients)
METABOLIC ACIDOSIS (158 patients)
PULMONARY OEDEMA (157 patients)
FEBRILE NEUTROPENIA (157 patients)
CHRONIC GRAFT VERSUS HOST DISEASE (155 patients)
DECREASED APPETITE (155 patients)
CONDITION AGGRAVATED (152 patients)
HEPATIC ENZYME INCREASED (151 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (150 patients)
HEPATIC FAILURE (148 patients)
FUNGAL INFECTION (147 patients)
BACTERAEMIA (147 patients)
HEPATITIS C (147 patients)
FATIGUE (147 patients)
BLOOD LACTATE DEHYDROGENASE INCREASED (147 patients)
BK VIRUS INFECTION (146 patients)
LIVER FUNCTION TEST ABNORMAL (145 patients)
HYPERGLYCAEMIA (145 patients)
HEART TRANSPLANT REJECTION (144 patients)
BONE MARROW FAILURE (144 patients)
INTERSTITIAL LUNG DISEASE (143 patients)
HEPATIC FUNCTION ABNORMAL (141 patients)
RASH (140 patients)
LYMPHADENOPATHY (139 patients)
CHOLANGITIS (139 patients)
BLOOD ALBUMIN DECREASED (139 patients)
C-REACTIVE PROTEIN INCREASED (138 patients)
DEEP VEIN THROMBOSIS (137 patients)
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY (136 patients)
HYDRONEPHROSIS (132 patients)
WOUND INFECTION (132 patients)
HYPERBILIRUBINAEMIA (132 patients)
TRANSPLANT FAILURE (131 patients)
WHITE BLOOD CELL COUNT INCREASED (130 patients)
CHILLS (128 patients)
OXYGEN SATURATION DECREASED (128 patients)
ARTHRALGIA (127 patients)
PAIN IN EXTREMITY (127 patients)
WOUND SECRETION (126 patients)
DIZZINESS (125 patients)
FALL (124 patients)
IMPAIRED HEALING (123 patients)
TRANSAMINASES INCREASED (122 patients)
URETERIC STENOSIS (122 patients)
HAEMORRHAGE (121 patients)
CONFUSIONAL STATE (121 patients)
BILE DUCT STENOSIS (121 patients)
KLEBSIELLA INFECTION (121 patients)
URINE OUTPUT DECREASED (120 patients)
PULMONARY EMBOLISM (119 patients)
POST PROCEDURAL BILE LEAK (119 patients)
WOUND DEHISCENCE (118 patients)
CHEST PAIN (117 patients)
CARDIAC FAILURE CONGESTIVE (117 patients)
OLIGURIA (116 patients)
POST PROCEDURAL HAEMORRHAGE (115 patients)
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED (115 patients)
HYPERLIPIDAEMIA (115 patients)
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE (114 patients)
GASTROENTERITIS VIRAL (111 patients)
WEIGHT INCREASED (111 patients)
CHOLECYSTITIS ACUTE (109 patients)
PNEUMATOSIS INTESTINALIS (109 patients)
PYELONEPHRITIS ACUTE (109 patients)
RESPIRATORY DISTRESS (108 patients)
TACHYCARDIA (106 patients)
GASTROINTESTINAL DISORDER (106 patients)
OSTEONECROSIS (106 patients)
HYPOXIA (105 patients)
KAPOSI'S SARCOMA (105 patients)
ASCITES INFECTION (104 patients)
MYOPATHY (103 patients)
GASTRITIS (103 patients)
MUCOSAL INFLAMMATION (103 patients)
COMPLICATIONS OF TRANSPLANTED LIVER (103 patients)
CONSTIPATION (102 patients)
BLOOD CULTURE POSITIVE (102 patients)
RHABDOMYOLYSIS (102 patients)
BRONCHIECTASIS (102 patients)
RENAL ARTERY STENOSIS (101 patients)
GASTRIC ULCER (101 patients)
BLOOD ALKALINE PHOSPHATASE INCREASED (101 patients)
SYSTEMIC LUPUS ERYTHEMATOSUS (101 patients)
LUNG INFECTION (100 patients)
LOSS OF CONSCIOUSNESS (99 patients)
DIALYSIS (99 patients)
CEREBROVASCULAR ACCIDENT (99 patients)
LUNG DISORDER (98 patients)
MUSCULAR WEAKNESS (98 patients)
LIVER DISORDER (97 patients)
HEPATOTOXICITY (97 patients)
HYPONATRAEMIA (97 patients)
THROMBOSIS (96 patients)
SURGERY (95 patients)
RENAL TUBULAR DISORDER (95 patients)
SKIN LESION (94 patients)
VIRAL INFECTION (94 patients)
CYTOMEGALOVIRUS ANTIGEN POSITIVE (94 patients)
ANOREXIA (93 patients)
HYPOGAMMAGLOBULINAEMIA (93 patients)
DRUG LEVEL INCREASED (92 patients)
CALCULUS URETERIC (92 patients)
RENAL TRANSPLANT (92 patients)
NEUTROPHIL PELGER-HUET ANOMALY PRESENT (91 patients)
HYPERCHOLESTEROLAEMIA (91 patients)
RENAL FAILURE CHRONIC (91 patients)
HYPERTRIGLYCERIDAEMIA (90 patients)
ENCEPHALOPATHY (90 patients)
PULMONARY HYPERTENSION (90 patients)
ANURIA (90 patients)
LACERATION (89 patients)
PNEUMOCYSTIS JIROVECI PNEUMONIA (89 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.

Recent FactMed Activity for MYCOPHENOLATE MOFETIL

Issue	Description / Topic	Timestamp
QUESTION SUDDEN HEARING LOSS	Is there any effect of mycophenolate mofetil on hearing? Does it cause sudden onset hearing loss?	2015-05-23 08:38:12
QUESTION NIGHTMARE	does mycophenolate cause nightmares?	2015-09-18 21:23:21
QUESTION MOBILITY DECREASED	My husband has Parkisons-like Symptoms. Could the fact that he takes Cellcept for a kidney transplant aggravate the the tremors and mobility problems?	2016-01-07 21:13:23
QUESTION BRONCHITIS	Is bronchitis a common side effect of CellCept?	2016-03-22 13:59:10
QUESTION DRUG INTERACTION	CAn mycophenolate interact with epilim	2016-07-07 01:06:33
QUESTION PALPITATIONS	PALPITATIONS and MYCOPHENOLATE MOFETIL (CELLCEPT) are they connected	2016-08-24 18:10:49
QUESTION GINGIVAL HYPERPLASIA	Does MYCOPHENOLATE MOFETIL cause gingival[gum] hyperplasia[overgrowth]?	2016-10-25 20:38:25
QUESTION DELUSION	My uncle has taken this drug for 3+ months. He is experiencing delusions. Is this a possible side effect of this drug?	2017-01-17 19:08:32
QUESTION DERMAL CYST	Does mycophenolate cause hearing loss?	2017-03-16 23:34:26
QUESTION ABDOMINAL PAIN	You can definitely see your expertise in the article you write.The arena hopes for more passionate writers like you who aren7#821&;t afraid to say how they believe. At all times go after your heart.	2017-03-20 09:02:00
QUESTION OSTEONECROSIS	Can Osteonecrosis be a side effect from taking Mycophenolate?	2017-04-11 16:47:49
QUESTION DEMENTIA	does mycophenolate cause dementia	2017-05-16 18:57:33
QUESTION TRANSIENT ISCHAEMIC ATTACK	I am taking cellcept. I have had transient ischemic attacks. Did cellcept cause them? I have also lost my sense of taste and smell.	2017-06-26 18:15:18

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME and MYCOPHENOLATE MOFETIL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.

Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking MYCOPHENOLATE MOFETIL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.

Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in MYCOPHENOLATE MOFETIL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.

We are currently accepting registration for MYCOPHENOLATE MOFETIL experts. If you are a healthcare provider experienced in prescribing MYCOPHENOLATE MOFETIL, please register here.